Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 5;17(3):e258215.
doi: 10.1136/bcr-2023-258215.

Raynaud's phenomenon associated with psoriatic arthritis

Mohd Jazman Che Rahim  1   2 , Jo Anne Lim  3   2 , Wan Syamimee Wan Ghazali  3   2
Affiliations
Case Reports

Raynaud's phenomenon associated with psoriatic arthritis

Mohd Jazman Che Rahim et al. BMJ Case Rep. .

Abstract

We report a case of Raynaud's phenomenon in a patient with psoriatic arthritis (PsA). A middle-aged right-handed housewife presented with complaints of severely painful hand discolouration for 1 week, which usually worsened with cold exposure. She was diagnosed with PsA 6 months earlier. Her PsA was well controlled with weekly methotrexate. Physical examination showed no features of scleroderma or skin necrosis of her right hand. Both radial pulses were strong and symmetrical. Her nailfolds were visibly normal. The extractable nuclear antigen panel and other blood investigations were negative for scleroderma and other possible causes of secondary Raynaud's phenomenon. Occupational or environmental factors were also excluded. Dermatoscope examination of the nailfolds revealed some areas of dilated capillary loops, areas of vascular sparing and proximal nail fold telangiectasia. The diagnosis of secondary Raynaud's phenomenon was made, and an oral calcium channel blocker was started. The patient had significant improvement in symptoms shortly afterwards.

Keywords: Dermatology; Rheumatology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Taylor W, Gladman D, Helliwell P, et al. . Classification criteria for Psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73. 10.1002/art.21972 - DOI - PubMed
    1. Smolen JS, Schoels M, Aletaha D. Disease activity and response assessment in Psoriatic arthritis using the disease activity index for Psoriatic arthritis (DAPSA). A brief review. Clin Exp Rheumatol 2015;33(5 Suppl 93):S48–50. - PubMed
    1. Temprano KK. A review of Raynaud’s disease. Mo Med 2016;113:123–6. Available: https://pubmed.ncbi.nlm.nih.gov/27311222 - PMC - PubMed
    1. Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol 2012;8:469–79. 10.1038/nrrheum.2012.96 - DOI - PubMed
    1. Sobolewski P, Maślińska M, Wieczorek M, et al. . Systemic sclerosis - Multidisciplinary disease: clinical features and treatment. Reumatologia 2019;57:221–33. 10.5114/reum.2019.87619 - DOI - PMC - PubMed

Publication types